Search Results 1141-1150 of 17013 for monoclonal antibody

  1. Publications - Harry H. Yoon, M.D. - Mayo Clinic

    ... monoclonal antibody ramucirumab. Ann Oncol. 2017 Dec 1; 28 (12):2932-2942. View PubMed; Yoon HH. Novel treatment strategies in carcinoma of unknown primary ...

  2. An Open-label Study to Investigate the Efficacy, Safety and Tolerability of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy - Mayo Clinic

    The subject has a history of immunoglobulin M (IgM) paraproteinemia, including IgM monoclonal gammopathy with high titer of antibody to myelin-associated ...

  3. A Study of AP160-Complex in Advanced Solid Tumors - Mayo Clinic

    STI-3031, a fully human anti-PDL1 recombinant monoclonal Ab, will be supplied by Sorrento. ... antibody do not count). Exclusion Criteria. Any of ... Anti-PD(L)1 ...

  4. Mayo-Adimune Collaborative and Programmatic Approach to Tolerization Therapy - Mayo Clinic

    The purpose of this study is to target two autoimmune neurological conditions that we consider proof of principal T cell- and antibody ... antibody titer greater ...

  5. Publications - Manish J. Gandhi, M.D. - Mayo Clinic

    Daratumumab interference in flow cytometric anti-granulocyte antibody testing can be overcome using non-human blocking antibodies. Vox Sang. 2021 Jan; 116 ...

  6. Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer - Mayo Clinic

    Use of targeted agents (e.g., monoclonal antibodies or kinase inhibitors) will not be counted as a prior chemotherapy treatment; Patients with known EGFR ...

  7. Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients (SAFE KIDNEY II) - Mayo Clinic

    Recipients who, in the opinion of the investigator, are likely to require antibody-depletion therapy during trial participation. Antibody-depleting ...

  8. Publications - Mary E. Fidler, M.D. - Mayo Clinic

    ... monoclonal gammopathy-associated kidney diseases. Kidney Int. 2021 Jul; 100 (1):155-170 Epub 2021 Mar 25. View PubMed; Said SM, Rocha AB, Valeri AM, Sandid M ...

  9. Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization - Mayo Clinic

    About this study. The purpose of this trial is to determine the safety and efficacy of eculizumab in the prevention of antibody mediated rejection (AMR) in ...

  10. Advances in lung cancer immunotherapy and management of immune-mediated adverse events - Mayo Clinic

    Monotherapy, using the anti-PD-1 antibody pembrolizumab, is now Food and Drug Administration (FDA) approved for patients with stage IV non-small cell lung ...